Brian Sanderoff is the director and principal owner of the Well Being Healing Center and Holistic Pharmacy in Hunt Valley, Maryland. In the past 25 years of clinical practice, Brian has been able to integrate his tradition medical training as a pharmacist with his experience and unique knowledge base in the realms of nutrition and herbalism into a practice geared towards finding the true underlying causes of diseases. Through careful examination and evaluation of a patients symptoms, health history, family history, lifestyle and stresses, Brian is able to devise a plan of action that helps attain the patients specific goals in a directed and timely manner. The tools of Brian's trade are nutritional and herbal supplements, advice about lifestyle ( including diet, exercise, sleep, stress reduction and coping mechanisms) and an intuitive sense of "health direction"

Louis Philipson, MD, PhD, is an endocrinologist and a leading world authority on diabetes mellitus. His clinical interests include type 1 diabetes, complicated type 2 diabetes, monogenic diabetes and hypoglycemia. Recognized for unmatched expertise in the treatment of diabetes that is difficult to manage, Dr. Philipson's multisciplinary team frequently accepts referrals and provides consultations. Under his leadership, Kovler Diabetes Center has been recognized as a one of only seven National Institutes of Health (NIH) Diabetes Research and Training Centers in the U.S. For more than 25 years, Dr. Philipson has tirelessly explored the biophysical, molecular and genetic aspects of insulin secretion, and the genetics of diabetes. He and his colleagues discovered rare insulin gene mutations that produce beta cell ER stress and, in turn, cause neonatal diabetes. In addition, Dr. Philipson and his colleagues are among the nation's leading experts on monogenic diabetes, following more than 100 patients diagnosed with neonatal diabetes and many others with maturity onset diabetes of the young (MODY) type diabetes. He also serves as co-director of the Human Islet Transplantation project at the University of Chicago. Dr. Philipson has served as principal investigator on numerous research projects. His work is widely published in biomedical journals, including the Proceedings of the National Academy of Sciences, Science, Nature, Diabetes, American Journal of Physiology and the Journal of Biological Chemistry. As president of the Chicago/Northern Illinois board of the American Diabetes Association and a member of its National Board, he has been invited to speak and present at scientific research conferences and symposia worldwide. In addition, Dr. Philipson is the recipient of numerous awards including ADA Research Awards and the National Disease Research Interchange (NDRI) Outstanding Scientist Award. He was also named the 2011 recipient of the Samuel Eichold II Memorial Award for Contributions in Diabetes by the American College of Physicians. Practice Locations The University of Chicago Medicine 5841 S. Maryland Avenue Chicago, IL 60637 Duchossois Center for Advanced Medicine 5758 S. Maryland Avenue Chicago, IL 60637

Dr. Rajan has a Ph.D in Human Biology and 12 years of experience in Medical Research. Dr. Rajan is a former faculty at the Kovler Diabetes Center, University of Chicago and has authored several research papers including a patent. Currently Dr. Rajan is the Founder and CEO of Prana Diabetes, a company that focuses on preventing and managing diabetes using the power of technology.

Diana Isaacs, Pharm.D., BCPS, BC-ADM, CDE, is a Clinical Associate Professor of Pharmacy Practice at Chicago State University College of Pharmacy (CSU-COP). In addition to teaching, Dr. Isaacs works as a Clinical Pharmacy Specialist in ambulatory care at the Edward Hines, Jr. VA Hospital where she treats patients with diabetes. Dr. Isaacs is also working on NIH funded research in the area of medication adherence.

Aaron J. Kowalski, Ph.D., was appointed JDRF's first Chief Mission officer in December 2014 and serves as a key link between JDRF and the broad diabetes community. Dr. Kowalski combines his professional experience as a scientist with his personal experience of living with type 1 diabetes (T1D) for over 30 years to help guide and champion JDRF's programs focused on creating a world without T1D. Dr. Kowalski is an internationally recognized expert in the area of diabetes technologies and has been a leader of JDRF's Artificial Pancreas Research Project, a multi-million dollar initiative that began in 2005 to accelerate the progress toward automated insulin-delivery systems. He has authored numerous articles on T1D research and was a coauthor of the landmark study in The New England Journal of Medicine that revealed the effectiveness of continuous glucose monitors in T1D management. Dr. Kowalski has traveled and spoken globally about diabetes research progress, and is known for his ability to translate science into easily understandable concepts. Dr. Kowalski has presented at many national and international scientific conferences, including the American Diabetes Association Annual Scientific Sessions, and was the keynote speaker at the 2009 Diabetes Technology Society Meeting. He has been a voice for diabetes research in the popular media, appearing on The Martha Stewart Show, dLife, Fox Business, and NPR, among others. He is often quoted in the print media, including The New York Times, The Wall Street Journal, USA Today, and People magazine. Dr. Kowalski is a member of the JDRF PEAK Program's expert panel and often speaks about the importance of exercise and diet in better diabetes control. While living with T1D, he has completed 17 marathons. Online, he often tweets (@aaronjkowalski) about exercise and diabetes and how all people with T1D can live their lives without limits.